Intractable seizures, developmental delay, and the ketogenic diet

Area of Science:

• Neurology
• Metabolic Disorders
• Pediatrics

Background:

• Glucose transporter type 1 (GLUT1) deficiency syndrome is a rare condition.
• It presents as a treatable cause of developmental delay and seizures in infants.
• GLUT1 deficiency should be considered in the differential diagnosis of infant intractable seizures.

Observation:

• Low cerebrospinal fluid glucose with normal blood glucose levels, in the absence of other abnormalities, indicates GLUT1 deficiency.
• Genetic analysis can confirm the diagnosis.
• Antiepileptic drugs are often ineffective for seizure control.

Findings:

• The ketogenic diet is the preferred treatment for managing seizures associated with GLUT1 deficiency.
• Early identification and prompt treatment are essential.

Implications:

• Early intervention can prevent or reduce the severity of developmental delays.
• Accurate diagnosis and appropriate management significantly improve patient prognosis.
• Highlights the importance of considering rare metabolic disorders in pediatric neurology.